- CATIE NewsCanadian study of people with HIV and hepatitis C co-infection finds that limited access to food is associated with higher levels of HIV in the blood and 10% ...
- These guidelines review the evidence supporting PrEP and provide recommendations on PrEP use in different populations.
- This colourful wall poster was designed to be used in clinics, hospitals or community agencies that need hepatitis C information. It lists hepatitis C medications by viral genotype so that patients…
- Chronic HIV infection is associated with relatively high levels of inflammation and a growing body of evidence suggests that inflammation may increase the risk ...
- As mentioned earlier in this issue of TreatmentUpdate, chronic HIV infection is associated with excessive levels of inflammation and activation of the immune ...
- Pitavastatin is approved in the U.S. but not yet in Canada for the normalization of cholesterol levels. A clinical trial of pitavastatin, called Reprieve, is ...
- Chronic HIV infection is associated with increased levels of inflammation. Researchers suspect that over the long-term this inflammation may be associated with ...
- Canakinumab is an antibody that has been designed to block a receptor on cells for the chemical signal (cytokine) IL-1b (interleukin-1beta). This receptor and ...
- In a double-blind, placebo-controlled, randomized study called Cantos, researchers gave placebo and different doses of canakinumab (sold as Ilaris) every three ...
- Canakinumab is an antibody that is used to treat rare inflammatory conditions. It works by interfering with a receptor for the chemical signal interleukin-1b ...